Amyris (NASDAQ:AMRS) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.21) by 109.52 percent. This is a 62.96 percent decrease over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $71.13 million which missed the analyst consensus estimate of $105.09 million by 32.32 percent. This is a 48.60 percent increase over sales of $47.87 million the same period last year.
DarioHealth Announces Co. Entered Into Contracts With Two Prominent Regional Providers In Hawaii And Georgia For Its Remote Patient Monitoring Services
DarioHealth Corp. (NASDAQ:DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into contracts with two prominent regional providers in Hawaii and Georgia for its Remote
